Aquestive Therapeutics CEO Liquidates $104K in Shares Amid Mixed Financial Signals
Daniel Barber, president and chief executive officer of Aquestive Therapeutics, Inc. (NASDAQ:AQST), executed a sale of 25,000 shares on June 15, 2026, realizing $104,010 from the transaction. The divestment occurred at prices between $4.14 and $4.235 per share, with a weighted average of $4.1604. Following this activity, Barber retains direct owner…